An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.
Category: Truvada (Drug)
-
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.